Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
MedAvail Holdings Inc (MDVLQ)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/25/2024: MDVLQ (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -71.82% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/25/2024 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 0.00M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -94.18 | 52 Weeks Range 0.00 - 0.00 | Updated Date 06/29/2025 |
52 Weeks Range 0.00 - 0.00 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -35.56 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -106.17% | Operating Margin (TTM) -1099.75% |
Management Effectiveness
Return on Assets (TTM) -68.15% | Return on Equity (TTM) -194.67% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -12094839 | Price to Sales(TTM) - |
Enterprise Value -12094839 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue 0.27 | Enterprise Value to EBITDA -0.24 | Shares Outstanding 1613910 | Shares Floating 1612684 |
Shares Outstanding 1613910 | Shares Floating 1612684 | ||
Percent Insiders 0.05 | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
MedAvail Holdings Inc
Company Overview
History and Background
MedAvail Holdings Inc. was founded in 2007. It focuses on offering technology-enabled pharmacy services and solutions designed to improve medication access, adherence, and patient outcomes.
Core Business Areas
- Medication Dispensing Kiosks: Develops and operates automated medication dispensing kiosks, providing convenient access to prescriptions.
- Telepharmacy Services: Offers remote pharmacist consultations and support through its telepharmacy platform.
- Medication Adherence Programs: Provides programs designed to improve patient adherence to medication regimens.
Leadership and Structure
The leadership team includes executive officers responsible for finance, operations, and technology. The organizational structure is designed to support its technology-driven healthcare solutions.
Top Products and Market Share
Key Offerings
- MedAvail MedCenters: Automated dispensing kiosks located in clinics and hospitals, offering on-site prescription fulfillment. Data on market share or number of users is not readily available. Competitors include InstyMeds and ScriptCenter.
- SpotRx: Telepharmacy platform providing remote consultations and medication management. Data on market share or number of users is not readily available. Competitors include TelePharm and iRx.
Market Dynamics
Industry Overview
The pharmacy automation and telepharmacy industry is growing due to increasing demand for convenient medication access, improved adherence, and cost reduction.
Positioning
MedAvail is positioned as a provider of technology-driven pharmacy solutions, focusing on automation and telepharmacy to improve patient outcomes. They aim to differentiate themselves through their integrated kiosk and telepharmacy platform.
Total Addressable Market (TAM)
The TAM for pharmacy automation and telepharmacy is estimated to be in the billions of dollars. MedAvail is positioning itself to capture a share of this market through its technology-driven solutions.
Upturn SWOT Analysis
Strengths
- Innovative technology platform
- Convenient medication access
- Improved medication adherence
- Telepharmacy capabilities
Weaknesses
- Limited market penetration
- High capital expenditure
- Regulatory hurdles
- Dependence on partnerships
Opportunities
- Expansion into new markets
- Partnerships with healthcare providers
- Increased adoption of telehealth
- Government support for pharmacy automation
Threats
- Competition from established pharmacies
- Changing regulations
- Data security risks
- Economic downturn
Competitors and Market Share
Key Competitors
- CVS
- WBA
- RAD
Competitive Landscape
MedAvail faces competition from established pharmacy chains and other technology providers. Its advantages include its integrated kiosk and telepharmacy platform. Disadvantages include limited market penetration and regulatory hurdles.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends analysis requires specific financial data that is not currently available.
Future Projections: Future projections based on analyst estimates are not available in this context.
Recent Initiatives: Recent initiatives include partnerships with healthcare providers and expansion of its kiosk network.
Summary
MedAvail Holdings Inc. operates in the growing pharmacy automation and telepharmacy market. Its technology-driven solutions and partnerships present opportunities for growth, but it faces competition from established players. The company's success depends on its ability to expand its market penetration and navigate regulatory challenges. It needs to improve market penetration and effectively scale its operations, the company is positioned to benefit from the increasing demand for convenient medication access and telehealth solutions.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings, Industry reports, News articles
Disclaimers:
The information provided is based on available data and analysis. It should not be considered investment advice. Market share data may not be precise and can vary based on source and methodology.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About MedAvail Holdings Inc
Exchange NASDAQ | Headquaters Phoenix, AZ, United States | ||
IPO Launch date - | CEO - | ||
Sector Healthcare | Industry Pharmaceutical Retailers | Full time employees 279 | Website https://medavail.com |
Full time employees 279 | Website https://medavail.com | ||
MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.